Regulus Therapeutics to Present at the 2025 Oppenheimer Innovation on the Island Biotech Summit
Regulus Therapeutics (Nasdaq: RGLS), a biopharmaceutical company specializing in microRNA-targeted medicine development, has announced its participation in the 2025 Oppenheimer Innovation on the Island Biotech Summit.
CEO Jay Hagan will deliver a presentation on Wednesday, April 9th at 11:32 a.m. ET. Investors and interested parties can access both the live event and replay through the company's investor relations website at https://ir.regulusrx.com/events. The presentation recording will remain accessible for 90 days following the event.
Regulus Therapeutics (Nasdaq: RGLS), un'azienda biofarmaceutica specializzata nello sviluppo di farmaci mirati ai microRNA, ha annunciato la sua partecipazione al 2025 Oppenheimer Innovation on the Island Biotech Summit.
Il CEO Jay Hagan terrà una presentazione mercoledì 9 aprile alle 11:32 ET. Gli investitori e le parti interessate possono accedere sia all'evento dal vivo che alla registrazione attraverso il sito web delle relazioni con gli investitori dell'azienda all'indirizzo https://ir.regulusrx.com/events. La registrazione della presentazione rimarrà accessibile per 90 giorni dopo l'evento.
Regulus Therapeutics (Nasdaq: RGLS), una empresa biofarmacéutica especializada en el desarrollo de medicamentos dirigidos a microARN, ha anunciado su participación en el 2025 Oppenheimer Innovation on the Island Biotech Summit.
El CEO Jay Hagan ofrecerá una presentación el miércoles 9 de abril a las 11:32 a.m. ET. Los inversores y partes interesadas pueden acceder tanto al evento en vivo como a la repetición a través del sitio web de relaciones con inversores de la empresa en https://ir.regulusrx.com/events. La grabación de la presentación estará disponible durante 90 días después del evento.
Regulus Therapeutics (Nasdaq: RGLS), 마이크로RNA 타겟 의약품 개발을 전문으로 하는 생명공학 회사가 2025 Oppenheimer Innovation on the Island Biotech Summit에 참가한다고 발표했습니다.
CEO Jay Hagan은 4월 9일 수요일 오전 11시 32분 ET에 발표를 진행할 예정입니다. 투자자와 관심 있는 분들은 회사의 투자자 관계 웹사이트 https://ir.regulusrx.com/events를 통해 실시간 이벤트와 재생 영상을 모두 이용할 수 있습니다. 발표 녹화는 이벤트 후 90일 동안 접근 가능합니다.
Regulus Therapeutics (Nasdaq: RGLS), une entreprise biopharmaceutique spécialisée dans le développement de médicaments ciblant les microARN, a annoncé sa participation au 2025 Oppenheimer Innovation on the Island Biotech Summit.
Le PDG Jay Hagan présentera une communication le mercredi 9 avril à 11h32 ET. Les investisseurs et les parties intéressées peuvent accéder à la fois à l'événement en direct et à la rediffusion via le site web des relations investisseurs de l'entreprise à l'adresse https://ir.regulusrx.com/events. L'enregistrement de la présentation restera accessible pendant 90 jours après l'événement.
Regulus Therapeutics (Nasdaq: RGLS), ein biopharmazeutisches Unternehmen, das sich auf die Entwicklung von mikroRNA-zielgerichteten Medikamenten spezialisiert hat, hat seine Teilnahme am 2025 Oppenheimer Innovation on the Island Biotech Summit bekannt gegeben.
CEO Jay Hagan wird am Mittwoch, den 9. April um 11:32 Uhr ET eine Präsentation halten. Investoren und Interessierte können sowohl auf die Live-Veranstaltung als auch auf die Wiederholung über die Investor Relations-Website des Unternehmens unter https://ir.regulusrx.com/events zugreifen. Die Aufzeichnung der Präsentation wird 90 Tage nach der Veranstaltung zugänglich bleiben.
- None.
- None.
The live event and replay of the presentation will be available under "Events and Presentations" through the investor relations section of the Company's website at https://ir.regulusrx.com/events and archived for 90 days following the presentation date.
About Regulus
Regulus Therapeutics Inc. (Nasdaq: RGLS) is a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs. Regulus has leveraged its oligonucleotide drug discovery and development expertise to develop a pipeline complemented by a rich intellectual property estate in the microRNA field. Regulus maintains its corporate headquarters in San Diego, CA.
View original content to download multimedia:https://www.prnewswire.com/news-releases/regulus-therapeutics-to-present-at-the-2025-oppenheimer-innovation-on-the-island-biotech-summit-302417580.html
SOURCE Regulus Therapeutics Inc.
FAQ
When is Regulus Therapeutics (RGLS) presenting at the 2025 Oppenheimer Biotech Summit?
How long will the RGLS Oppenheimer presentation replay be available?
Where can investors watch Regulus Therapeutics' (RGLS) Oppenheimer Summit presentation?
What is the focus area of Regulus Therapeutics (RGLS)?
